Post-thrombotic Syndrome Clinical Trial
Official title:
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
The goal of this study is to determine the safety and tolerability or efficacy of adjunctive treatments (including rosuvastatin 20 mg daily) in combination with standard anticoagulation therapy (Factor Xa inhibitors) in patients with lower extremity deep vein thrombosis (DVT). The efficacy of adjunctive treatments to prevent the development of post thrombotic syndrome (PTS) after DVT will be evaluated.
Post-thrombotic syndrome (PTS) is a significant complication that occurs up to 75% of patients after DVT. Rosuvastatin is a HMGCoA reductase inhibitor that has anti-inflammatory effects. In this study, the investigators will evaluate the safety and tolerability of combination standard anticoagulation therapy (e.g. Factor Xa inhibitor, rivaroxaban, apixaban) and three months of 20 mg dose of rivaroxaban and its efficacy as prophylaxis against PTS after lower extremity DVT. After the diagnosis of lower extremity DVT with either duplex venous ultrasound or other imaging, study participants will initiate standard rivaroxaban therapy as per standard medical care. All consented participants in this trial will receive three months of rosuvastatin (20 mg daily dose). Assessment of post thrombotic syndrome follow up will continue for 365 days from the time of DVT diagnosis or until resolution or stabilization of any clinically significant drug related adverse event, after which they will be considered off-study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02512601 -
Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
|
Phase 4 | |
| Completed |
NCT01432795 -
Practicability of Gliding Aids for Medical Compression Stockings
|
Phase 4 | |
| Completed |
NCT01578122 -
Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
|
N/A | |
| Withdrawn |
NCT01615692 -
The 36-month Extension to Follow up Sub Study
|
||
| Withdrawn |
NCT02767232 -
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
|
Phase 3 | |
| Completed |
NCT02159521 -
Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System
|
Phase 4 | |
| Recruiting |
NCT05701917 -
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
|
N/A | |
| Completed |
NCT02433054 -
Bern Venous Stent Registry
|
||
| Active, not recruiting |
NCT03833024 -
The MUFFIN-PTS Trial
|
Phase 3 | |
| Completed |
NCT02942394 -
Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study
|
||
| Completed |
NCT01846780 -
Treadmill Pilot Study (Invasive Pressure Measurements in PTS)
|
N/A | |
| Active, not recruiting |
NCT03195777 -
Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT
|
N/A |